TMO
NYSE HealthcareThermo Fisher Scientific Inc Common Stock
Diagnostics & Research
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
๐ Market Data
| Price | $543.19 |
|---|---|
| Volume | 1,895,505 |
| Market Cap | 201.86B |
| Dividend Yield % | 0.35% |
| Beta | 0.870 |
| RSI (14-Day) | 71.4 Overbought |
| 200-Day MA | $528.00 |
| 50-Day MA | $482.57 |
| 52-Week High | $643.99 |
| 52-Week Low | $403.36 |
| P/E Ratio | 29.85 |
| Forward P/E | 19.93 |
| Price / Book | 3.89 |
๐ฏ Investment Strategy Scores
TMO scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Institutional Whale (97/100) โ this strategy Large-cap, institutional-quality stocks.
Lowest fit among scored strategies: ๐ช Falling Knife (31/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find TMO in your text
Paste any article, transcript, or post โ the tool will extract TMO and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-07-16.